An Implanted Brain Monitor for Epilepsy Was Cleared for Adolescents as Young as 12

The FDA cleared an expansion of Epiminder's implanted Minder EEG monitoring system to adolescents as young as 12 with drug-resistant epilepsy, extending a system previously limited to adults. The under-the-scalp implant streams brain activity to a wearable and phone app for up to three years of use, giving clinicians a longer view of seizures in younger patients.